2007
DOI: 10.1016/j.thromres.2007.03.023
|View full text |Cite
|
Sign up to set email alerts
|

Pulsed-high intensity focused ultrasound enhanced tPA mediated thrombolysis in a novel in vivo clot model, a pilot study

Abstract: Introduction-Thrombotic disease continues to account for significant morbidity and mortality. Ultrasound energy has been investigated as a potential primary and adjunctive treatment for thrombotic disease. We have previously shown that pulsed-high intensity focused ultrasound (HIFU) enhances thrombolysis induced by tissue plasminogen activator (tPA) in vitro, including describing the non-destructive mechanism by which tPA availability and consequent activity is increased. In this study we aimed to determined i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
61
0

Year Published

2008
2008
2021
2021

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 69 publications
(63 citation statements)
references
References 37 publications
(58 reference statements)
2
61
0
Order By: Relevance
“…In these same studies where tumor growth was monitored, those treated with HIFU only were found to grow at rates not significantly slower than untreated controls, providing further evidence of the non-destructive nature of these exposures. The same exposures used for thrombolysis studies similarly showed no destructive effects, both in vitro [144] and in vivo [154].…”
Section: Safety Considerationsmentioning
confidence: 73%
See 2 more Smart Citations
“…In these same studies where tumor growth was monitored, those treated with HIFU only were found to grow at rates not significantly slower than untreated controls, providing further evidence of the non-destructive nature of these exposures. The same exposures used for thrombolysis studies similarly showed no destructive effects, both in vitro [144] and in vivo [154].…”
Section: Safety Considerationsmentioning
confidence: 73%
“…A -a schematic representation showing how non-focused ultrasound exposures using a plane wave transducer (1) are used to treat superficially, whereas a concave tranducer (2), housed in a coupling bath of degassed water (DW), can be used to place the focal zone (FZ) of the beam deeper inside the body; B -tranducer head of a dual probe showing the concave bowl therapeutic transducer for producing a focused beam and the collinear imaging tranducer for treatment planning of the exposure. This device was modified from a Sonoblate 500 (Focus Surgery, Indianapolis, IN) and used for some of the preclinical studies described in this review [57][58][59]61,[142][143][144][145][146][147][148][149]151,153,154,157,163]; C -representative lateral and vertical B mode ultrasound scans of a subcutaneous tumor in a murine flank. The two long horizontal lines indicate the focal zone (FZ) of the transducer and the shorter vertical lines, the raster (treatment) points for the exposures.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…65 FUS for the treatment of ischemic stroke, however, remains in the early preclinical phase, with in vitro and animal models having demonstrated initial feasibility. 16,61 MRgFUS has also been explored for thrombolysis in intraparenchymal hemorrhage. Results from a cadaveric animal model of intracranial hemorrhage demonstrated that FUS led to sufficient clot liquefaction to allow for needle aspiration of the lysate.…”
Section: Intracranial Thrombolysismentioning
confidence: 99%
“…Maxwell et al reported that histotripsy therapy using short, HIFU pulses can cause mechanical breakdown of targeted soft tissue by acoustic cavitation, which is guided by real-time ultrasound imaging [2,3]. Moreover, a study has shown the effectiveness of pursed HIFU in vitro and in vivo to enhance thrombolysis induced by tissue plasminogen activator (tPA) [17,18].…”
Section: Introductionmentioning
confidence: 99%